Tonix Pharmaceuticals.
commercial pharmaceutical company
- Reports this week
- 0
- Active events
- 1
- Connections
- 33
What's happening
Active this week
Earlier this month
-
The FDA approved Tonix Pharmaceuticals' drug, Tonmya, for use in treating fibromyalgia.Well supported6 reports
-
Tonix Pharmaceuticals announced it will present at a conference in Boston.Some support1 report
-
Seth Lederman, formerly of Aliaxis, has joined Tonix Pharmaceuticals to lead AI initiatives.Some support1 report
One to three months ago
-
Max Baucus highlighted biotech community growth while Tonix Pharmaceuticals CEO Seth Lederman discussed plans for a new facility in Ravalli County, Montana.Some support1 report
-
Tonix Pharmaceuticals CEO Seth Lederman purchased company stock in an insider transaction, while analyst coverage influences stock rating.Some support1 report
-
Tonix Pharmaceuticals and Valneva are both identified as small-cap healthcare companies.Some support3 reports
-
Market comparison of small-cap biotechs involving Tonix Pharmaceuticals and Protalix Biotherapeutics.Some support1 report
Gone quiet
No new reports in 90+ days-
Tonix Medicines, Inc. became a commercial subsidiary of Tonix Pharmaceuticals on July 21, 2025.Some support1 report
-
Tonix Pharmaceuticals was included in the Russell indexes on July 1, 2025.Speculative2 reports
-
Tonix Pharmaceuticals announced a collaboration with Columbia University Medical School, and Seth Lederman was identified as the CEO of the company.Speculative1 report
-
Tonix Pharmaceuticals is conducting the OASIS study at the University of North Carolina, where Sina Bavari serves as Executive Vice President of Infectious Disease Research and Development.Speculative1 report
-
Tonix Pharmaceuticals conducted an OASIS study at the University of North Carolina.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Tonix Pharmaceuticals
Events traced to Tonix Pharmaceuticals, step by step, newest firstAround Tonix Pharmaceuticals this week
News at the entities that move Tonix Pharmaceuticals most-
FDA StructuralIndian products were subject to an FDA recall.Moves Tonix Pharmaceuticals
-
Medicare TransactionalJeffries is poised to become Speaker of the House while the House pushes for Medicare for All and reverses Medicaid cuts.Moves Tonix Pharmaceuticals
-
MarketBeat Mentioned togetherMarketBeat used its stock screener tool to highlight Walmart.Moves Tonix Pharmaceuticals
-
Boston Shared contextFAA ground stops and air traffic disruptions caused flight delays between Boston, Tampa, and Los Angeles on November 1, 2026.Moves Tonix Pharmaceuticals
Connections
The 11 strongest of 33, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Seth Lederman Structural
Seth Lederman serves as the Chief Executive Officer and President of Tonix Pharmaceuticals.
-
FDA Structural
The FDA formally regulated Tonix Pharmaceuticals, granting designations and final approval for its drug Tonmya.
-
University of North Carolina Structural
Tonix Pharmaceuticals utilizes the University of North Carolina for clinical trials and drug development studies.
-
Medicare Transactional
Tonix Pharmaceuticals secured managed payer agreements with Medicare.
-
International Association for the Study of Pain Shared context
Tonix Pharmaceuticals presented research at an International Association for the Study of Pain congress.
-
MarketBeat Mentioned together
MarketBeat provides analyst ratings and market coverage for Tonix Pharmaceuticals.
-
Valneva SE Mentioned together
Both Valneva SE and Tonix Pharmaceuticals are described as small-cap healthcare companies.
-
Frederick Shared context
Tonix Pharmaceuticals operates a research facility located in Frederick, Maryland.
Show all 11 connections
-
Raymond James Financial Mentioned together
Raymond James Financial provides analyst coverage that influences Tonix Pharmaceuticals' stock rating and price.
-
Ravalli County Shared context
Tonix Pharmaceuticals plans to establish a new facility in Ravalli County to support the local Montana economy.
-
Boston Shared context
Tonix Pharmaceuticals is scheduled to present at a conference held in Boston.
History
Events by the month they beganNovember 2026
3 eventsOctober 2026
1 eventSeptember 2026
3 events- Tonix Pharmaceuticals CEO Seth Lederman purchased company stock in an insider transaction, while analyst coverage influences stock rating.
- Tonix Pharmaceuticals and Valneva are both identified as small-cap healthcare companies.
- Market comparison of small-cap biotechs involving Tonix Pharmaceuticals and Protalix Biotherapeutics.
Show 1 earlier month
June 2026
6 events- The FDA approved Tonix Pharmaceuticals' drug, Tonmya, for use in treating fibromyalgia.
- Tonix Medicines, Inc. became a commercial subsidiary of Tonix Pharmaceuticals on July 21, 2025.
- Tonix Pharmaceuticals was included in the Russell indexes on July 1, 2025.
- Tonix Pharmaceuticals announced a collaboration with Columbia University Medical School, and Seth Lederman was identified as the CEO of the company.
- Tonix Pharmaceuticals is conducting the OASIS study at the University of North Carolina, where Sina Bavari serves as Executive Vice President of Infectious Disease Research and Development.
- Tonix Pharmaceuticals conducted an OASIS study at the University of North Carolina.